Federal Enforcement Landmark • DOJ Healthcare False Claims Probe
Based on Reuters Legal coverage of the DOJ’s $9.5M dual-hospital settlement resolving billing probe allegations. Adjust legal parameters, qui tam relator incentives, and multi-year compliance monitoring costs below.
Preset Scenario:
Lead System Share
64.5% of settlement
A
Co-Defendant Share
35.5% of settlement
B
Total Exposure
$11,100,000
Settlement + Legal + Yr 1 Ops
Whistleblower Payout
$1,710,000
18.0% relator bounty
Total Monitoring Exp.
$1,050,000
Over 3-yr CAP period
Effective Penalty Ratio
40.4%
Settlement / Claims Disputed
Global Settlement Parameters
False Claims Act Bounds
$9,500,000
$1.0M
$25.0M
$50.0M
18%
10% (DOJ Intervened Floor)
18% (Standard)
30% (Ceiling)
$1,250,000
3 Years
$350,000
Participating Hospital System Parameters
Relative Exposure Weighting
Hospital System A (Lead System)
Hospital System B (Co-Defendant)
Settlement Distribution & Financial Burden Breakdown
Government Recovery vs. Relator Payout vs. Compliance Operations
Corrective Action Plan (CAP) Milestone Projection
Independent Review Organization (IRO) audits, policy overhauls & training
| Period / Milestone | Compliance Focus | Lead System A | Co-Def System B | Total Exp. |
|---|
Institutional Impact & Severity Matrix
Financial exposure expressed against annual operational revenue
Hospital System A (Lead)
$7,160,000 Total Exp
Settlement Contribution:
$6,125,000
Legal Defense Share:
$805,851
CAP Monitoring Share:
$676,915
% of Annual System Revenue:
0.597%
Hospital System B (Co-Defendant)
$3,940,000 Total Exp
Settlement Contribution:
$3,375,000
Legal Defense Share:
$444,149
CAP Monitoring Share:
$373,085
% of Annual System Revenue:
0.464%
📖 Statutory Regulatory Notes & False Claims Act (31 U.S.C. §§ 3729–3733) Guidance
Qui Tam Relator Provisions: Under the federal False Claims Act, private relators (whistleblowers) who initiate claims are statutorily entitled to 15% to 25% of proceeds if the DOJ intervenes, or up to 30% if pursuing without federal intervention.
Settlement Cost Apportionment: Joint defendants may apportion civil monetary settlements proportionally by alleged false claims billing volume, net Medicare/Medicaid reimbursements, or enterprise scale.
Corporate Integrity Agreements (CIA): HHS-OIG typically mandates 3-year or 5-year monitoring including an Independent Review Organization (IRO) to verify claims accuracy and compliance hotline integrity.